Levonorgestrel IUS cost effective for heavy menstrual bleeding
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2017 Category: Drugs & Pharmacology Source Type: news

Taboo around vaginal bleeding endangers women's health
(Columbia University's Mailman School of Public Health) The culture of silence around vaginal bleeding at all stages of life endangers women's health and is compounded by limited access to clean water, sanitation, and factual information in low and middle-income countries, according to a study conducted at Columbia University's Mailman School of Public Health. An approach that looks at vaginal bleeding as more than a monthly period and addresses the needs of girls and women across the life course is urgently required. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 31, 2017 Category: International Medicine & Public Health Source Type: news

Excellance Finishes New CNG Unit for Bossier City Fire Dept. Before Heading to Pinnacle 2017
Excellance just finished a new Compressed Natural Gas (CNG) unit for Bossier City Fire Department before heading off to Pinnacle this year. These new emergency vehicles created for the Bossier City Fire Department are stylish, powerful, and sleek. CNG units burn cleaner, so they’re great for the environment – but they’re also great on your bottom line, boasting significantly lower fuel costs compared to standard gas and diesel engines. Bossier City’s switch to CNG has saved over $7,000 per vehicle in fuel costs annually. Excellance’s CNG vehicles get up to 7 miles a gallon, compared to 3 &A...
Source: JEMS: Journal of Emergency Medical Services News - July 30, 2017 Category: Emergency Medicine Authors: Excellance Tags: Industry News Operations Source Type: news

Excellance Finishes New CNG Unit for Bossier City Fire Dept. Before Heading to Pinnacle 2017
Excellance just finished a new Compressed Natural Gas (CNG) unit for Bossier City Fire Department before heading off to Pinnacle this year. These new emergency vehicles created for the Bossier City Fire Department are stylish, powerful, and sleek. CNG units burn cleaner, so they’re great for the environment – but they’re also great on your bottom line, boasting significantly lower fuel costs compared to standard gas and diesel engines. Bossier City’s switch to CNG has saved over $7,000 per vehicle in fuel costs annually. Excellance’s CNG vehicles get up to 7 miles a gallon, compared to 3 &A...
Source: JEMS Operations - July 30, 2017 Category: Emergency Medicine Authors: Excellance Tags: Industry News Operations Source Type: news

Medical News Today: Implantation bleeding: Causes and symptoms
Learn about the bleeding that occurs when a fertilized egg attaches to the lining of the uterus, including signs and symptoms, and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 29, 2017 Category: Consumer Health News Tags: Pregnancy / Obstetrics Source Type: news

Slug slime inspires new surgical glue
(Reuters) – Scientists have developed an experimental surgical glue inspired by the mucus secreted by slugs that could offer an alternative to sutures and staples for closing wounds. While some medical glues already exist, they often adhere weakly, are not particularly flexible and frequently cannot be used in very wet conditions. To get around those problems, a group of scientists from Harvard and other research centers decided to learn from slugs, which – as well as making slime to glide on – can produce extremely adhesive mucus as a defense mechanism. The slugs’ trick is to generate a substance t...
Source: Mass Device - July 28, 2017 Category: Medical Devices Authors: MassDevice Tags: Research & Development Surgical Wound Care Source Type: news

Patients at-risk of bleeding are given anticoagulants
Researchers from the University of Birmingham found that patients with an irregular heartbeat who are at risk of bleeding are almost just as likely to be prescribed anticoagulants as those without. (Source: the Mail online | Health)
Source: the Mail online | Health - July 28, 2017 Category: Consumer Health News Source Type: news

Resumption of Anticoagulation for AF After Major Bleeding Resumption of Anticoagulation for AF After Major Bleeding
Should anticoagulation for AF be resumed after a patient experiences an anticoagulation-related major bleeding event?Evidence-Based Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2017 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Stretchy glue inspired by slugs could be the future of sutures
  Inspired by slug slime, scientists have developed a flexible adhesive that sticks to wet surfaces. This stretchy glue can be attached to a beating, bleeding heart and could someday replace stitches in wound repair. Other commercially available glues create strong but inflexible bonds or stretchy but weak connections. The slug-inspired glue cements tightly and […]Related:New debate on antibiotics: Do you really need to take the full course?These experimental treatments target brain cancer like John McCain’sSperm concentration has declined 50 percent in 40 years in three continents (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - July 27, 2017 Category: Consumer Health News Source Type: news

Clinical Trial to Study If 3-Months of DAPT is Safe After XIENCE Stent
The study, called XIENCE Short DAPT, will evaluate if 3 months of DAPT is non-inferior to the current standard of 12 months after implantation with a XIENCE stent for patients who are at high risk of bleeding. The study will enroll approximately 2,000 patients at 100 sites in the U.S. and Asia. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - July 26, 2017 Category: Cardiology Source Type: news

MassDevice.com +5 | The top 5 medtech stories for July 25, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. How a single drop of blood can detect sepsis Sepsis can be identified by a single drop of blood, thanks to a lab-on-a-chip device from the University of Illinois. Researchers at the University of Illinois and the Carle Foundati...
Source: Mass Device - July 25, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Saving Vanessa, part 1: A mystery rash, a stroke and an epic rescue
Vanessa’s rash first appeared on her arms and legs when she 3 or 4 months old. It was red and bumpy and went away when she was sick with a virus, which happened often. Then it would come back. The dermatology team she saw at Boston Children’s Hospital was puzzled. “I was expecting they were going to think it was nothing, but they took it very seriously,” says Katherine Bell, one of Vanessa’s mothers. “They took a biopsy and very quickly realized they had no idea what it was.” Vanessa’s case was even featured at a regional dermatology conference where doctors take up mystery p...
Source: Thrive, Children's Hospital Boston - July 25, 2017 Category: Pediatrics Authors: Nancy Fliesler Tags: Diseases & Conditions Our Patients’ Stories Dr. Carolyn Rogers Dr. Pui Lee Dr. Robert Sundel Dr. Scellig Stone Dr. Todd Lyons stroke Source Type: news

Abbott to study blood thinners after treatment with Xience drug-eluting stent
Abbott (NYSE:ABT) said today that it enrolled the first patient in a trial evaluating the short-term use of blood thinning drugs, called dual antiplatelet therapy, after implantation of the company’s Xience everolimus-eluting coronary stent. The 2,000-patient study is slated to assess if three months of DAPT is non-inferior to the current standard of 12 months for patients at high risk of bleeding. Get the full story at our sister site, Drug Delivery Business News. The post Abbott to study blood thinners after treatment with Xience drug-eluting stent appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 25, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Drug-Device Combinations Drug-Eluting Stents Wall Street Beat Abbott Source Type: news

Abbott Initiates Clinical Trial of Three-month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent
- Trial will evaluate amount of time patients at high risk of bleeding should receive blood thinning medicine after treatment with XIENCE (Source: Abbott.com)
Source: Abbott.com - July 25, 2017 Category: Pharmaceuticals Source Type: news

What Conditions is Erythema Nodosum Associated With?
Patient Presentation A 12-year-old male came to clinic with a history of 3-4 days of painful bruising on his shin and lower arms. He had Streptocococcal pharyngitis diagnosed by rapid strep testing approximately 4 weeks previously and had taken all of his amoxicillin antibiotic per his parents. He had recovered without any problems until 3-4 days ago when his legs and arms started to have painful bruises along the shins and lower arms. They were raised, red/purple and painful mainly in the center of the lesions. He denied pain elsewhere nor any fever (Tmax was 99.5F), chills, sweats, weight loss, joint stiffness, abdomina...
Source: PediatricEducation.org - July 24, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Education and Innovation Take Center Stage at ImageTrend Connect
The second day of the ImageTrend Connect conference, held this week at the Saint Paul (Minn.) RiverCentre, kicked off on Thursday with a two-part keynote address that educated attendees on the EMS aspects of protecting the homeland. First up was Eric Chaney, Medical First Responder Branch chief in the Office of Health Affairs (OHA), which leads biodefense, health and medical efforts at the U.S. Department of Homeland Security (DHS). The OHA sits at a unique intersection between law enforcement, homeland security and public health, playing a role in everything from disaster response to managing federal efforts in treating a...
Source: JEMS Administration and Leadership - July 21, 2017 Category: Emergency Medicine Authors: Ryan Kelley, NREMT Tags: News Administration and Leadership Source Type: news

Education and Innovation Take Center Stage at ImageTrend Connect
The second day of the ImageTrend Connect conference, held this week at the Saint Paul (Minn.) RiverCentre, kicked off on Thursday with a two-part keynote address that educated attendees on the EMS aspects of protecting the homeland. First up was Eric Chaney, Medical First Responder Branch chief in the Office of Health Affairs (OHA), which leads biodefense, health and medical efforts at the U.S. Department of Homeland Security (DHS). The OHA sits at a unique intersection between law enforcement, homeland security and public health, playing a role in everything from disaster response to managing federal efforts in treating a...
Source: JEMS: Journal of Emergency Medical Services News - July 21, 2017 Category: Emergency Medicine Authors: Ryan Kelley, NREMT Tags: News Administration and Leadership Source Type: news

Bayer ’s Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation requiring oral Anticoagulation and undergoing Percutaneous Coronary Intervention with Stent Placement (for specialized target groups only)
Positive CHMP Opinion is based on data from the Phase IIIb PIONEER AF-PCI study, which demonstrated significantly reduced rates of clinically significant bleeding with Xarelto compared with VKA in patients with non-valvular atrial fibrillation (AF) who require oral anticoagulation and are also receiving antiplatelet therapy after percutaneous coronary intervention (PCI) with stent placement (1) / PIONEER AF-PCI is the first and currently only randomised clinical trial of a non-vitamin K antagonist oral anticoagulant (NOAC) in this patient population / Final decision of European Commission expected by the end of this year (...
Source: Bayer Company News - July 21, 2017 Category: Pharmaceuticals Source Type: news

21.07.17: Not intended for U.S. and UK Media
Bayer's Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation requiring oral Anticoagulation and undergoing Percutaneous Coronary Intervention with Stent PlacementPositive CHMP Opinion is based on data from the Phase IIIb PIONEER AF-PCI study, which demonstrated significantly reduced rates of clinically significant bleeding with Xarelto compared with VKA in patients with non-valvular atrial fibrillation (AF) who require oral anticoagulation and are also receiving antiplatelet therapy after percutaneous coronary intervention (PCI) with stent...
Source: Bayer IR Newsfeed: Events - July 20, 2017 Category: Pharmaceuticals Source Type: news

Bleeding Common Years After TAVR, and Deadly Bleeding Common Years After TAVR, and Deadly
Registry findings highlight an underappreciated risk after transcatheter aortic valve replacement -- late nonaccess site bleeding -- and the pressing need to fine-tune postprocedure anticoagulant and antiplatelet therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 20, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

New harmless radiopaque glue to seal bleeding and guide surgery
(Institute for Basic Science) First nanoparticle-based adhesive with imaging contrast effect in CT and ultrasound was successfully tested in animals and showed less toxicity than the FDA-approved glue CA-Lp. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 19, 2017 Category: Biology Source Type: news

Lawsuit: New TennCare rates endanger hemophilia patients
A Tennessee lawsuit claims the state is breaking federal law and putting people with bleeding disorders like hemophilia in great danger by reimbursing less for prescription blood-clotting drugs through its Medicaid program (Source: ABC News: Health)
Source: ABC News: Health - July 18, 2017 Category: Consumer Health News Tags: Health Source Type: news

Bleeding After TAVR Predicts Mortality (CME/CE)
(MedPage Today) -- Access-site bleeds not as risky as other bleeds in Swiss center study (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 18, 2017 Category: Cardiology Source Type: news

Tool Predicts Safe ED Discharge for Those With Lower GI Bleeding Tool Predicts Safe ED Discharge for Those With Lower GI Bleeding
Researchers have developed a tool that can help assess when patients with acute lower gastrointestinal bleeding can safely be managed as outpatients.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 18, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news

Clinic for women with bleeding disorders follows women through life cycles
(Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - July 17, 2017 Category: Hospital Management Tags: Hospital News Source Type: news

Idarucizumab Shows Reliable Reversal of Dabigatran
Effective for dabigatran reversal among patients with uncontrolled bleeding, undergoing urgent surgery (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 13, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Oncology, Orthopedics, Pharmacy, Pulmonology, Surgery, Anesthesiology & Pain, Conference News, Source Type: news

Early-stage wound care dev Gel-e raises $3m
Early stage wound care company Gel-e said today it raised $3.1 million to support its hemostatic and wound care platform. The round was led by unnamed early-stage investment funds and life science investors, the College Park, Md.-based company said. Gel-e said that financing will help support initial FDA clearance for products designed to manage bleeding wounds, including vascular access sites to a “broader hemostatic product line” for treating external wounds. The company said it aims to produce a “broad range of game-changing hemostatic and wound treatment products,” which include bandages, foams ...
Source: Mass Device - July 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Wound Care gel-e Source Type: news

FDA Grants De Novo Clearance for Z-Medica ’s QuikClot Control+ Only Non-Absorbable Hemostatic Dressing for Severe Bleeding in Internal Organ Space
Wallingford, Conn. - Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces that QuikClot Control+ has been cleared for use by the US Food and Drug Administration (FDA) under the de novo classification process and is designated as a Class II medical device. QuikClot Control+ is the first and only non-absorbable hemostatic dressing cleared for internal organ space use in severely bleeding patients. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may also be used for control of severely bleeding wound...
Source: JEMS Patient Care - July 13, 2017 Category: Emergency Medicine Authors: Dave Schemelia Tags: Patient Care Industry News Source Type: news

FDA Grants De Novo Clearance for Z-Medica ’s QuikClot Control+ Only Non-Absorbable Hemostatic Dressing for Severe Bleeding in Internal Organ Space
Wallingford, Conn. - Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces that QuikClot Control+ has been cleared for use by the US Food and Drug Administration (FDA) under the de novo classification process and is designated as a Class II medical device. QuikClot Control+ is the first and only non-absorbable hemostatic dressing cleared for internal organ space use in severely bleeding patients. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may also be used for control of severely bleeding wound...
Source: JEMS: Journal of Emergency Medical Services News - July 13, 2017 Category: Emergency Medicine Authors: Dave Schemelia Tags: Patient Care Industry News Source Type: news

An Approach to Acute Lower Gastrointestinal Bleeding An Approach to Acute Lower Gastrointestinal Bleeding
This clinical review covers the assessment, etiology, imaging, and management of acute lower GI bleeding.Frontline Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 13, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Z-Medica wins FDA de novo nod for QuickClot Control+
Hemostatic device developer Z-Medica said today it won FDA de novo clearance for its QuickClot Control+, now indicated for temporary control of internal organ space bleeding for patients displaying Class III or Class IV bleeding. The Wallingford, Conn.-based company touted its QuickClot Control+ as the 1st and only non-absorbable hemostatic dressing with clearance for internal organ space in severely bleeding patients, and added that it may also be used for control of severely bleeding wounds including surgical wounds and traumatic injuries. “This clearance marks another major milestone in the growth of our comp...
Source: Mass Device - July 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Z-Medica Source Type: news

Nerve Blockade vs. Intrathecal Morphine for TKA Nerve Blockade vs. Intrathecal Morphine for TKA
For patients undergoing total knee arthroplasty, which provides better analgesia and control of post-op bleeding: intrathecal morphine or a continuous femoral plus single-shot sciatic nerve block?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Treatment rapidly reverses the effect of blood thinner dabigatran
At least 28 million prescriptions for blood thinners are filled by pharmacists yearly for the irregular heartbeat of atrial fibrillation, deep vein thrombosis, and other indications, according to the Department of Health and Human Services. However, on rare occasions, anticoagulants can present risks of accidental bleeding and hemorrhage or can delay emergency surgery. A newly completed phase III clinical study demonstrates the safety and efficacy of idarucizumab, a novel therapy that acts as an antidote to the blood thinner dabigatran. (Source: World Pharma News)
Source: World Pharma News - July 11, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Disruptive technology reduces bleeding in hemophilia by 87 percent
Researchers at Children's Hospital Los Angeles developed a new therapy called emicizumab that decreases bleeding episodes by nearly 90 percent. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 10, 2017 Category: Consumer Health News Source Type: news

Book Review: Scared Selfless
Dr. Michelle Stevens’ new book, Scared Selfless: My Journey from Abuse and Madness to Surviving and Thriving, powerfully weaves the story of a survivor of a child sex ring with the astounding facts about one of society’s most cloaked secrets. “I had noticed that we, as a society, are fed a steady stream of news of stories about abductions, fallen clergy, and child pornography. But despite all the TV ratings and magazine sales these stories garner, we seem to know very little about sexual abuse and why it occurs,” writes Stevens. Sex is a taboo subject. But sex with a child – unspeakable. And y...
Source: Psych Central - July 10, 2017 Category: Psychiatry Authors: Claire Nana Tags: Abuse Book Reviews Dissociative Trauma Child Abuse Dissociative Identity Disorder Dr. Michelle Stevens Molestation Rape Sexual Abuse Sexual Trauma Source Type: news

Medical News Today: Bleeding ulcer: What causes it and is it serious?
What are the symptoms of a bleeding ulcer and what causes peptic ulcers? Learn about the diagnosis, treatment, outlook, and myths about bleeding ulcers. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 10, 2017 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news

Disruptive technology for the treatment of hemophilia
(Children's Hospital Los Angeles) An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence of bleeding episodes by 87 percent. Results of this multicenter phase III study called HAVEN 1, will be presented at the International Society of Thrombosis and Hemostasis and published in the New England Journal of Medicine on July 10. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2017 Category: International Medicine & Public Health Source Type: news

WHO issues warning about rise of drug-resistant gonorrhoea
Conclusion The increase in antimicrobial resistance towards drugs used to treat gonorrhoea is reaching a critical stage, especially given how common the infection is worldwide, with an estimated 78 million new cases in 2012. This study raises concerns around an important topic while also proposing strategies to help address the slow pace of research and development of new drugs. The prevention of gonorrhoea is equally, if not more, important. The most effective way to prevent gonorrhoea is to always use a condom during sex, including anal and oral sex. Read more advice about sexually transmitted infections and how to prev...
Source: NHS News Feed - July 7, 2017 Category: Consumer Health News Tags: Medication QA articles Source Type: news

FDA updates on Baxter Vascu-Guard patch recall
The FDA today released an update on Baxter‘s (NYSE:BAX) voluntary recall of its Vascu-Guard peripheral vascular patch, saying that it is working with the company but that neither group has discovered a root cause for the issues, which led to a number of adverse events and 3 potential patient deaths. The Vascu-Guard patch is designed for use in vascular reconstruction surgeries including carotid, renal, iliac, femoral, profund and tibial blood vessels and arteriovenous access revisions, the FDA said. While the federal watchdog said it has yet to discover the cause of the issue, it did offer that so far, there have bee...
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Recalls Vascular Baxter Source Type: news

The Risk of Lower GI Bleeding in Low-dose Aspirin Users The Risk of Lower GI Bleeding in Low-dose Aspirin Users
How significant is the risk of lower gastrointestinal bleeding in low-dose aspirin users?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Johnson & Johnson fields Aussie class action over pelvic mesh
(Reuters) – Australian women have brought a class-action case against Johnson & Johnson (NYSE:JNJ) over complications arising from vaginal mesh implants – a lawsuit that follows many others in the United States, Canada and Europe. The claim, which is being heard in Australia’s Federal Court, said patients had suffered chronic pain, bleeding and severe discomfort during sexual intercourse since having the mesh surgically implanted. The devices are used to treat stress urinary incontinence and pelvic organ prolapse. The Australian action was brought on behalf of more than 700 claimants. Johnson &am...
Source: Mass Device - July 5, 2017 Category: Medical Devices Authors: MassDevice Tags: Legal News Women's Health johnsonjohnson Source Type: news

Death From Bleeding After Cancer-Related VTE in Elderly Death From Bleeding After Cancer-Related VTE in Elderly
The rates are low, but the risk for death from a major bleeding event following a cancer-related thromboembolism (VTE) is much higher than the risk associated with a recurrent VTE in older patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Heartburn drugs linked to premature death
Conclusion This larger set of observational data finds that PPI drugs are associated with an increase in the risk of early death compared with either H2 blockers or no acid suppression drugs. This was the case for participants both with and without gastrointestinal problems. It also appears as though the longer the PPIs drugs are taken, the greater the risk of death. Considering that these drugs are widely used in the UK, these findings may cause concern. But the research has a number of important limitations: The study was conducted in a population of mostly white, older US male veterans, which might limit the abi...
Source: NHS News Feed - July 4, 2017 Category: Consumer Health News Tags: Medication Source Type: news

Concussion Can Spur Short-Term Change in Women's Periods
Odds of abnormal menstrual bleeding jump 6 times after serious head injury, study says Source: HealthDay Related MedlinePlus Pages: Concussion, Menstruation, Teen Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 3, 2017 Category: Consumer Health News Source Type: news

Is concussion associated with abnormal menstrual patterns in young women?
(The JAMA Network Journals) A study of nearly 130 girls and young women suggests concussion was associated with increased risk of having two or more abnormal menstrual bleeding patterns, according to an article published by JAMA Pediatrics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2017 Category: International Medicine & Public Health Source Type: news

Bio2 touts pivotal data on Angel catheter-filter combo
This study of a combined IVC filter/central venous catheter was the culmination of a panel of dedicated investigators with careful guidance by the FDA,” primary investigator Dr. Victor Tapson said in prepared remarks. “The efficacy and safety of the device, simple bedside placement, and the need to remove it before discharge make it very appealing. Nearly the entire cohort had crucial, yet short-term filter needs so that discharge without a filter was preferred.” The device is the 1st to be cleared by the FDA for PE prophylaxis in critically ill patients contraindicated to anticoagulation. “The publ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Catheters Clinical Trials Vascular BiO2 Medical Source Type: news

Hologic files infringement suit against Fujifilm Medical over mammogram tech
Fujifilm Holdings (TSE:4901) subsidiary Fujifilm Medical Systems is facing a patent infringement suit from Hologic (NSDQ:HOLX), which claims that the company infringed on 5 of its mammogram technology patents, according to a Connecticut Law Tribune report. The suit, filed in the US District Court for the District of Connecticut on Monday claims that Japan-based Fujifilm “had specific intent to infringe the ‘296 patent or were willfully blind to such infringement,” according to the report. The patents relate to Hologic’s Selenia Dimensions digital breast tomosynthesis system, which was issu...
Source: Mass Device - June 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Legal News Mammography Patent Infringement Women's Health Hologic Source Type: news

Oral Anticoagulation in ESRD and AF: Just Say No to Drugs? Oral Anticoagulation in ESRD and AF: Just Say No to Drugs?
The presence of CKD in patients with AF is associated with increased stroke risk--but also a heightened risk of bleeding. Are anticoagulants safe for stroke prevention in these patients?Heart (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 27, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Channel Medsystems wins CE Mark for Cerene cryotherapy device
Channel Medsystems said today it won CE Mark approval in the European Union for its Cerene cryotherapy endometrial ablation device designed for treating women with heavy menstrual bleeding due to benign causes. The Emeryville, Calif.-based company said that current endometrial ablation procedures can be painful and require general anesthesia, but its Cerene device and associated procedure are comfortable and usable in an office setting with no post-procedure downtime. “Finding the right treatment can be a challenge for women. The introduction of the Cerene procedure in Europe will allow gynecologists t...
Source: Mass Device - June 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Women's Health Channel Medsystems Source Type: news